Amoéba Raises €6.67 Million and Defers Debt Balance to 2029
Amoéba has announced the successful completion of its capital increase through a private placement, raising €6.67 million from institutional investors. This move is part of a financial strengthening strategy to support the ramp-up of industrial operations and the commercial launch of its microbiological solutions.
Funding to Accelerate Industrial and Commercial Initiatives
The funds raised will enable Amoéba to accelerate the industrial ramp-up initiated through contracts with external CDMO providers. They will also finance the marketing and commercial support for developments undertaken by distribution partners and will support the development strategy in the cosmetics sector. The capital increase involves 8,897,973 new shares, representing 11.43% of the post-operation share capital. The settlement-delivery and the admission of the shares on Euronext Growth are scheduled for March 30, 2026.
Debt Refinancing Agreement Negotiated
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Amoéba has negotiated a debt refinancing agreement with its reference shareholder Nice & Green, allowing the repayment of the bulk of its bond debt to be postponed to 2029. By combining the net proceeds from the capital increase, available liquidity, and the new repayment schedule, the Company estimates it can ensure its development and meet its financial commitments at least until December 31, 2026. Nice & Green's participation remains stable at 22.87% of the capital after the operation.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
